Related Experiment Video
Updated: May 25, 2026

Blood Flow Imaging with Ultrafast Doppler
Published on: October 14, 2020
Evaluating imaging and computer-aided detection and diagnosis devices at the FDA
Brandon D Gallas1, Heang-Ping Chan, Carl J D'Orsi
1Division of Imaging and Applied Mathematics, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993-0002, USA. brandon.gallas@fda.hhs.gov
The Joint FDA-MIPS Workshop focused on improving statistical methods and study designs for evaluating medical imaging and computer-assisted devices. Key outcomes include identifying knowledge gaps for future research in device performance evaluation.
Area of Science:
- Medical imaging device evaluation
- Computer-assisted diagnostic systems
- Statistical methodology in healthcare
Background:
- The workshop convened experts to discuss the current state of science for evaluating imaging and computer-assisted devices.
- The primary goal was to foster consensus on statistical methods and study designs for regulatory submissions.
- Participants aimed to identify knowledge gaps and unmet needs in the field.
Framework:
- Focus on robust statistical methods for imaging device evaluation.
- Development of standardized study designs for computer-assisted diagnostic tools.
- Establishing best practices for regulatory submissions to the US Food and Drug Administration (FDA).
Implementation:
- Summarizing discussions from the Joint FDA-MIPS Workshop.
- Disseminating lessons learned from past studies on device performance.
- Facilitating consensus on evaluation methodologies for imaging and CADx devices.
Implications:
- Advancing the scientific rigor in medical device evaluation.
- Improving the quality and reliability of regulatory submissions.
- Guiding future research to address identified knowledge gaps in device performance.
More Related Videos
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Drug Regulation
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
FDA Approved Drugs: Changes to Approved Drugs
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT